Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Shanghai Stock Exchange 603392.SS
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 15.31
-
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 52-week high Price to Sales Ratio (P/S) is 18.72 on October 08, 2024, which is 22.30% above the current Price to Sales Ratio (P/S).
-
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 52-week low Price to Sales Ratio (P/S) is 11.59 on February 02, 2024, which is -24.24% below the current Price to Sales Ratio (P/S).
-
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 15.70.
| Date | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield |
|---|
| CEO | Mr. Tao Yu |
| IPO Date | April 29, 2020 |
| Location | China |
| Headquarters | No. 31 Kexueyuan Road |
| Employees | 3,843 |
| Sector | Health Care |
| Industries | |
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. researches, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides COVID 19, HIV and HTLV, Hepatitis, EV-71, and Tuberculosis diagnostics test kits; Hepatitis C and Syphilis detection reagents; automated immunoassays; ELISA kits and rapid tests for infectious disease diagnostics; chemiluminescence and clinical chemistry reagents; immunodiagnostic reagents; and Hepatitis E and human papillomavirus vaccines. It serves blood banks, hospitals and clinics, reference laboratories, border inspection centers, blood-processing companies, and research institutes. The company was founded in 1991 and is headquartered in Beijing, China.
Past 5 years
USD 3.45
USD 24.66
USD 4.53
USD 28.52
StockViz Staff
January 15, 2025
Any question? Send us an email